Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
367M
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
28.3M
-
Shares change
-
+1.94M
-
Total reported value, excl. options
-
$1.16B
-
Value change
-
+$122M
-
Put/Call ratio
-
1.06
-
Number of buys
-
51
-
Number of sells
-
-29
-
Price
-
$41.05
Significant Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q2 2021
105 filings reported holding LEGN - Legend Biotech Corp - COMMON STOCK as of Q2 2021.
Legend Biotech Corp - COMMON STOCK (LEGN) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.3M shares
of 367M outstanding shares and own 7.71% of the company stock.
Largest 10 shareholders include Capital International Investors (2.69M shares), FEDERATED HERMES, INC. (2.01M shares), CAPITAL INTERNATIONAL INC /CA/ (1.95M shares), ALLIANCEBERNSTEIN L.P. (1.9M shares), Hudson Bay Capital Management LP (1.88M shares), BAKER BROS. ADVISORS LP (1.66M shares), Consonance Capital Management LP (1.65M shares), Johnson & Johnson Innovation - JJDC, Inc. (1.63M shares), MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC (1.34M shares), and Capital World Investors (1.19M shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.